GO:0034355 NAD+ biosynthetic process via the salvage pathway: NAD+ Recycling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034355 describes the salvage route that recycles vitamin B3 derivatives (nicotinamide, nicotinic acid, nicotinamide riboside, nicotinate riboside) into NAD+ without de novo synthesis.
• The pathway is enzymatically centered on NAMPT, NMNATs, NRKs, and NAD+ consumers such as SIRT1 and PARPs, which together maintain cellular NAD+ pools.
• NAD+ salvage is essential for cancer cell viability, and its modulation can influence p73-dependent apoptosis and ferroptosis sensitivity.
• Infectious disease research shows that blocking the NAD salvage pathway impairs schistosome metabolism, reproduction, and survival.
• Human studies demonstrate that different NAD+ boosters (NR, NMN, NAM) differentially affect circulatory NAD and microbial metabolism.
• NAD+ salvage is implicated in calcific aortic valve disease, renal ischemia-reperfusion injury, and glioma, making it a broad therapeutic target.
Description
NAD+ (nicotinamide adenine dinucleotide) is a central redox cofactor and signaling molecule, and its cellular levels are maintained by a balance between de novo synthesis and salvage from vitamin B3 derivatives. The Gene Ontology term GO:0034355, NAD+ biosynthetic process via the salvage pathway, captures the set of chemical reactions that regenerate NAD+ from nicotinamide (NAM), nicotinic acid (NA), nicotinamide riboside (NR), or nicotinate riboside (NAR) without de novo synthesis. This salvage route is often the dominant source of NAD+ in mammalian cells and is therefore a focal point for research on metabolism, aging, and disease. Researchers study GO:0034355 because it connects nutrient availability to fundamental processes such as DNA repair, mitochondrial function, and cell survival. The pathway is enzymatically simple but highly regulated: NAMPT converts NAM to NMN, NMNATs convert NMN to NAD+, and NRKs feed NR into the same intermediate pool. Because NAD+ is consumed by sirtuins, PARPs, and CD38, the salvage pathway must continuously replenish the pool to sustain signaling and redox homeostasis. Dysregulation of NAD+ salvage has been linked to cancer, neurodegeneration, metabolic disorders, and infectious disease. For example, inhibition of the salvage pathway can reduce cancer cell viability via p73, while activation of NAMPT protects against renal ischemia-reperfusion injury through the NAD+/SIRT1/PGC-1α axis. These findings make GO:0034355 a high-value target for CRISPR-based functional genomics and therapeutic development.
NAD+ biosynthetic process via the salvage pathway At A Glance
| GO ID | GO:0034355 |
|---|---|
| GO term | NAD+ biosynthetic process via the salvage pathway |
| Ontology | biological_process |
| Synonym | NAD biosynthetic process via the salvage pathway; NAD salvage; NAD salvage pathway |
| Major function | Regeneration of NAD+ from vitamin B3 derivatives (NAM, NA, NMN, NR, NAR) without de novo synthesis |
| Key enzymes | NAMPT, NMNAT1/2/3, NRK1/2, and NAD+ consumers such as SIRT1 and PARPs |
| Substrates | Nicotinamide (NAM), nicotinic acid (NA), nicotinamide riboside (NR), nicotinate riboside (NAR), and NMN |
| Cellular location | Cytoplasm, nucleus, and mitochondria, depending on the enzyme isoform |
| Related pathways | De novo NAD+ synthesis, NAD+ phosphorylation, and NAD+ consumption by sirtuins and PARPs |
What Is GO:0034355?
GO:0034355 is defined as the chemical reactions and pathways resulting in the formation of nicotinamide-adenine dinucleotide (NAD+) from vitamin B3 derivatives, including nicotinic acid (NA) and nicotinamide (NAM), beta-nicotinamide D-ribonucleotide (NMN), nicotinamide riboside (NR), or nicotinate riboside (NAR), without de novo synthesis. In other words, it is the recycling route that salvages NAD+ from dietary or metabolic precursors rather than building it from scratch.
Why Is NAD+ biosynthetic process via the salvage pathway Important in Cell Biology?
GO:0034355 is important because NAD+ salvage is the primary mechanism by which most cells maintain NAD+ levels, and this pool is required for redox reactions, DNA repair, mitochondrial function, and cell survival. Perturbations in the salvage pathway have been directly linked to cancer cell viability, ferroptosis sensitivity, renal injury, and parasitic infection, making it a compelling target for both basic research and therapeutic intervention.
• Maintains cellular NAD+ pools that are essential for glycolysis, oxidative phosphorylation, and redox homeostasis.
• Supports sirtuin and PARP activities that regulate DNA repair, stress responses, and aging.
• Modulates cancer cell viability through p73-dependent apoptosis.
• Regulates ferroptosis sensitivity in glioma via SIRT1 and ATF3.
• Is a validated drug target in schistosomes, where inhibition impairs parasite survival.
• Protects against renal ischemia-reperfusion injury via NAMPT and the NAD+/SIRT1/PGC-1α pathway.
• Is affected by senescence-associated metabolic alterations in calcific aortic valve disease.
• Shows differential systemic effects depending on the NAD+ booster used (NR, NMN, NAM) in humans.
• Provides a metabolic vulnerability that can be exploited in cancer and infectious disease.
• Is a key node for CRISPR screens aimed at identifying metabolic dependencies.
What Happens During NAD+ biosynthetic process via the salvage pathway?
Uptake and conversion of vitamin B3 precursors
In simple terms: The cell takes in vitamin B3-related molecules and converts them into a common intermediate.
The salvage pathway begins with the import or generation of vitamin B3 derivatives such as nicotinamide (NAM), nicotinic acid (NA), nicotinamide riboside (NR), and nicotinate riboside (NAR). NR is phosphorylated by nicotinamide riboside kinases (NRK1/2) to NMN, while NAM is converted to NMN by nicotinamide phosphoribosyltransferase (NAMPT). These reactions funnel multiple precursors into the shared intermediate NMN, ensuring that NAD+ can be regenerated from dietary and metabolic sources without de novo synthesis.
Formation of NAD+ from NMN
In simple terms: The intermediate NMN is converted into NAD+ by a family of enzymes.
Nicotinamide mononucleotide adenylyltransferases (NMNAT1, NMNAT2, and NMNAT3) catalyze the final step of the salvage pathway, converting NMN to NAD+. NMNAT1 is nuclear, NMNAT2 is cytoplasmic, and NMNAT3 is mitochondrial, allowing NAD+ regeneration in distinct cellular compartments. This compartmentalization is critical because NAD+ is consumed locally by sirtuins, PARPs, and other enzymes, and the salvage pathway must replenish each pool.
Consumption and feedback regulation
In simple terms: NAD+ is constantly used up, so the salvage pathway must keep working to maintain levels.
NAD+ is consumed by sirtuins (e.g., SIRT1), poly(ADP-ribose) polymerases (PARPs), and CD38, which generate nicotinamide (NAM) as a byproduct. This NAM can be recycled back into NAD+ via NAMPT, creating a salvage loop. The activity of this loop is regulated by circadian rhythms, cellular stress, and energy status, and its dysfunction leads to NAD+ depletion and metabolic collapse.
Integration with cellular stress and disease
In simple terms: When the salvage pathway fails, cells become vulnerable to stress and disease.
In cancer cells, inhibition of the NAD+ salvage pathway reduces viability through p73-dependent apoptosis, suggesting that some tumors rely on this route for survival. In glioma, SIRT1 activation by AROS sensitizes cells to ferroptosis via NAD+ depletion-dependent activation of ATF3. In renal ischemia-reperfusion injury, activation of NAMPT protects against damage through the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6. These examples illustrate how the salvage pathway is both a metabolic hub and a disease modifier.
Key Genes Involved in GO:0034355 NAD+ biosynthetic process via the salvage pathway
The following genes and proteins are core components or regulators of the NAD+ biosynthetic process via the salvage pathway (GO:0034355).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAMPT | Converts nicotinamide (NAM) to NMN, rate-limiting enzyme of the salvage pathway | Target for cancer, inflammation, and renal injury studies |
| NMNAT1 | Nuclear NMNAT that converts NMN to NAD+ | Mutations linked to retinal degeneration; nuclear NAD+ pool |
| NMNAT2 | Cytoplasmic NMNAT that converts NMN to NAD+ | Axon survival and neurodegeneration models |
| NMNAT3 | Mitochondrial NMNAT that converts NMN to NAD+ | Mitochondrial NAD+ homeostasis and metabolism |
| NRK1 | Phosphorylates nicotinamide riboside (NR) to NMN | NAD+ booster metabolism and human trials |
| NRK2 | Phosphorylates nicotinamide riboside (NR) to NMN | Tissue-specific NAD+ salvage |
| SIRT1 | NAD+-dependent deacetylase that consumes NAD+ and regulates stress responses | Ferroptosis, renal injury, and aging research |
| PARP1 | NAD+-consuming enzyme involved in DNA repair | DNA damage response and NAD+ depletion |
| CD38 | NAD+ glycohydrolase that consumes NAD+ and generates NAM | Immune regulation and aging |
| ATF3 | Transcription factor activated by NAD+ depletion in ferroptosis | Glioma ferroptosis sensitivity |
| p73 | Tumor suppressor mediating apoptosis upon NAD+ salvage inhibition | Cancer cell viability and chemotherapy response |
| PGC-1α | Downstream effector of NAD+/SIRT1 signaling in renal protection | Mitochondrial biogenesis and ischemia-reperfusion injury |
| NFκB | Inflammatory transcription factor modulated by NAD+ salvage in renal injury | Inflammation and tissue protection |
| TNF-α | Pro-inflammatory cytokine modulated by NAD+ salvage | Renal ischemia-reperfusion injury |
| IL-6 | Cytokine modulated by NAD+ salvage in injury models | Inflammation and tissue repair |
| NADSYN1 | De novo NAD+ synthesis enzyme, not part of salvage but relevant for comparison | Distinguishing salvage from de novo pathways |
| QPRT | De novo NAD+ synthesis enzyme, not part of salvage | Metabolic pathway discrimination |
| SLC22A13 | Potential transporter of nicotinate riboside (NAR) | Precursor uptake studies |
How Is NAD+ biosynthetic process via the salvage pathway Regulated?
The NAD+ salvage pathway is regulated at multiple levels. NAMPT expression is controlled by circadian clock components, inflammatory signals, and metabolic stress, and its activity is feedback-inhibited by NAD+ itself. SIRT1 and PARP1 consume NAD+ and generate NAM, which can be recycled by NAMPT, creating a dynamic loop that responds to cellular energy status and DNA damage. In humans, different NAD+ boosters (NR, NMN, NAM) differentially affect circulatory NAD and microbial metabolism, indicating that precursor availability and gut microbiota also regulate systemic NAD+ salvage. Additionally, senescence-associated metabolic alterations can impair NAD+ salvage in calcific aortic valve disease, linking aging to pathway dysfunction.
NAD+ biosynthetic process via the salvage pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAMPT | Renal ischemia-reperfusion injury; cancer metabolism | Nampt conditional knockout or overexpression in renal tubular cells |
| SIRT1 | Glioma ferroptosis; renal protection | SIRT1 knockout or point-mutation glioma cell lines |
| p73 | Cancer cell viability upon NAD+ salvage inhibition | TP73 knockout or overexpression in cancer cells |
| ATF3 | Ferroptosis sensitivity in glioma | ATF3 knockout or knock-in reporter glioma models |
| NMNAT2 | Neurodegeneration and axon survival | Nmnat2 knockout or tagged knock-in neurons |
Cancer and ferroptosis
The NAD+ salvage pathway modulates cancer cell viability via p73, and its inhibition can trigger apoptosis in tumor cells. In glioma, SIRT1 activated by AROS sensitizes cells to ferroptosis through NAD+ depletion-dependent activation of ATF3, highlighting a metabolic vulnerability that could be exploited therapeutically. These findings suggest that targeting GO:0034355 may be effective in cancers that depend on robust NAD+ recycling.
Renal ischemia-reperfusion injury
Activation of NAMPT protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6. This indicates that boosting the salvage pathway can be renoprotective, and that NAMPT is a potential therapeutic target in acute kidney injury.
Calcific aortic valve disease and aging
Senescence-associated metabolic alterations aggravate calcific aortic valve disease, and NAD+ salvage is among the pathways affected. This links age-related NAD+ decline to valvular calcification and suggests that maintaining salvage capacity may slow disease progression.
Infectious disease
Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival, demonstrating that this pathway is essential for the parasite and can be targeted for anti-schistosomal therapy. This expands the disease relevance of GO:0034355 beyond human metabolism to host-pathogen interactions.
From NAD+ biosynthetic process via the salvage pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NAMPT reduce NAD+ and affect cell survival? | NAMPT knockout cell lines (CRISPR KO) |
| Does a specific point mutation in NMNAT1 alter enzymatic activity? | NMNAT1 point-mutation knock-in cells |
| Can we track NAD+ salvage flux in live cells? | Tagged knock-in of NMNAT2 or NAMPT with fluorescent reporter |
| Does overexpression of NRK1 enhance NR utilization? | NRK1 overexpression cell lines |
| Which genes are essential for NAD+ salvage in cancer? | Genome-wide CRISPR library screening |
| Does SIRT1 activation sensitize glioma to ferroptosis? | SIRT1 overexpression or point-mutation glioma cells |
How to Study the NAD+ biosynthetic process via the salvage pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-nicotinamide tracing | Flux through NAD+ salvage pathway | Cancer and metabolic disease models |
| CRISPR knockout screen | Genes essential for NAD+ salvage-dependent growth | Cancer cell line panels |
| NAD+ biosensor imaging | Real-time NAD+ levels in subcellular compartments | Live-cell metabolism studies |
| RNA-seq | Expression changes in salvage genes | Senescence and disease models |
| Proteomics | Protein abundance of NAMPT, NMNATs, SIRT1 | Renal injury and inflammation studies |
| Enzymatic cycling assay | Total NAD+ concentration | Tissue and cell extracts |
| Mass spectrometry | NAD+ and precursor levels | Human clinical samples |
| CRISPR point-mutation knock-in | Effect of specific mutations on enzyme function | Structure-function studies |
Metabolic flux analysis
Stable isotope tracing with 13C-labeled nicotinamide or nicotinamide riboside can quantify flux through the NAD+ salvage pathway and distinguish it from de novo synthesis. This method is typically applied in cancer and metabolic disease models to measure NAD+ turnover.
CRISPR knockout and point-mutation screens
Genome-wide CRISPR knockout screens can identify genes required for NAD+ salvage-dependent cell growth, while point-mutation knock-ins can dissect catalytic residues in NAMPT or NMNATs. These approaches are used to discover metabolic vulnerabilities in cancer and infectious disease.
NAD+ quantification and imaging
NAD+ levels can be measured by enzymatic cycling assays, mass spectrometry, or genetically encoded biosensors such as Peredox or NAD+ sensors. Live-cell imaging with tagged NMNAT2 or NAMPT knock-ins allows spatial tracking of salvage activity.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal how NAD+ salvage gene expression changes under stress, senescence, or drug treatment. These methods are applied to identify regulatory networks and biomarkers in diseases such as calcific aortic valve disease and renal injury.
How CRISPR Can Be Used to Study GO:0034355 NAD+ biosynthetic process via the salvage pathway
Knockout
CRISPR knockout of NAMPT, NMNATs, or NRKs can abolish NAD+ salvage and reveal dependencies in cancer, renal injury, and parasitic infection. For example, NAMPT knockout reduces NAD+ and protects against renal ischemia-reperfusion injury in models.
Point Mutation
Point-mutation knock-in of catalytic residues in NAMPT or NMNAT1 can dissect enzymatic mechanisms and separate salvage from de novo synthesis. Such models are valuable for understanding how specific mutations affect NAD+ homeostasis.
Knock-in
Tagged knock-in of NMNAT2 or NAMPT with fluorescent or affinity tags enables live-cell imaging and proteomic analysis of the salvage machinery. This approach helps track subcellular localization and interactions.
Overexpression
Overexpression of NRK1 or NAMPT can enhance NAD+ salvage and protect against injury, as shown for NAMPT in renal ischemia-reperfusion. Overexpression models are used to test whether boosting the pathway is therapeutic.
How EDITGENE Supports NAD+ biosynthetic process via the salvage pathway Research
Researchers studying NAD+ biosynthetic process via the salvage pathway-related genes often need to determine whether a candidate gene is causally involved in NAD+ homeostasis, disease progression, or drug response. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for NAD+ biosynthetic process via the salvage pathway research.
Frequently Asked Questions About NAD+ biosynthetic process via the salvage pathway
What is GO:0034355?
GO:0034355 is the Gene Ontology term for NAD+ biosynthetic process via the salvage pathway, which regenerates NAD+ from vitamin B3 derivatives such as nicotinamide and nicotinamide riboside without de novo synthesis.
What genes are involved in NAD+ biosynthetic process via the salvage pathway?
Key genes include NAMPT, NMNAT1, NMNAT2, NMNAT3, NRK1, NRK2, SIRT1, PARP1, and CD38.
Why is the NAD+ salvage pathway important for cancer?
It supports cancer cell viability, and its inhibition can trigger p73-dependent apoptosis and ferroptosis in tumor cells.
How is NAD+ salvage regulated?
It is regulated by circadian rhythms, cellular stress, feedback inhibition by NAD+, and precursor availability, with SIRT1 and PARP1 consuming NAD+ and generating nicotinamide for recycling.
What diseases are linked to NAD+ salvage dysfunction?
Cancer, glioma, renal ischemia-reperfusion injury, calcific aortic valve disease, and schistosomiasis have been linked to altered NAD+ salvage.
What methods are used to study NAD+ salvage?
Common methods include 13C tracing, CRISPR knockout screens, NAD+ biosensors, RNA-seq, proteomics, and mass spectrometry.
Can CRISPR be used to model NAD+ salvage pathway mutations?
Yes, CRISPR knockout, point-mutation knock-in, and tagged knock-in are widely used to dissect gene function in this pathway.
What is the difference between de novo and salvage NAD+ synthesis?
De novo synthesis builds NAD+ from tryptophan or aspartate, while the salvage pathway recycles vitamin B3 derivatives such as nicotinamide and nicotinamide riboside.
Do NAD+ boosters affect the salvage pathway?
Yes, different NAD+ boosters such as NR, NMN, and NAM differentially impact circulatory NAD and microbial metabolism in humans.
How does NAMPT protect against kidney injury?
NAMPT activation protects against renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6.
Conclusion
GO:0034355, NAD+ biosynthetic process via the salvage pathway, is a fundamental metabolic route that maintains NAD+ levels and influences cancer, ferroptosis, renal injury, aging, and infectious disease. Its enzymatic components, especially NAMPT and NMNATs, are attractive targets for therapeutic intervention and metabolic research. CRISPR-based models and functional genomics are essential for dissecting the pathway and translating these findings into new treatments.
References
- 1. Qian X et al.. 2026. Senescence-associated metabolic alterations aggravate calcific aortic valve disease.. Eur Heart J 47(30):4133-4153 PMID: 41841768
- 2. Sharif T et al.. 2016. The NAD(+) salvage pathway modulates cancer cell viability via p73.. Cell Death Differ 23(4):669-80 PMID: 26586573
- 4. Chen X et al.. 2024. SIRT1 activated by AROS sensitizes glioma cells to ferroptosis via induction of NAD+ depletion-dependent activation of ATF3.. Redox Biol 69:103030 PMID: 38181705
- 5. Christen S et al.. 2026. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans.. Nat Metab 8(1):62-73 PMID: 41540253
- 6. Schultz MD et al.. 2020. Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival.. PLoS Pathog 16(5):e1008539 PMID: 32459815
- 7. Gasparrini M et al.. 2021. Enzymology of extracellular NAD metabolism.. Cell Mol Life Sci 78(7):3317-3331 PMID: 33755743
- 8. Elmorsy EA et al.. 2025. Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD(+)/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6.. Eur J Pharm Sci 214:107302 PMID: 41033563
